Twin antibodies that may help fight COVID-19 identified


PTI, May 14, 2020, 2:49 PM IST

Beijing: Scientists have identified a pair of neutralizing antibodies isolated from a patient who recovered from COVID-19 — that may offer therapeutic benefits, and help design molecule antivirals and vaccine candidates to fight the SARS-CoV-2 virus.

The antibodies identified by the researchers, including those from the Chinese Academy of Sciences, bind to the glycoprotein spike of the SARS-CoV-2 virus, blocking the spike’s ability to bind to the human ACE2 receptor and mediate viral entry into host cells.

Preliminary tests of the two antibodies, named B38 and H4, in a mouse model, resulted in a reduction of virus titers, the researchers said.

The finding, published in the journal Science, suggests that the antibodies may offer therapeutic benefits — in addition to informing the design of small molecule therapeutics and vaccine candidates to fight COVID-19, they said.

Researcher Yan Wu from Capital Medical University, China, and colleagues found that the antibodies can each bind simultaneously to different epitopes on the spike’s receptor-binding domain (RBD).

“Due to this binding, both antibodies together may confer a stronger neutralizing effect than either antibody on its own a prediction supported by in vitro experiments,” they said.

This feature also means that should one of the viral epitopes mutate in a way that prevents the binding of one of the two antibodies, the other may still retain its neutralizing activity, according to the researchers.

“By imaging, the structure of the viral spike’s RBD bound to B38, the team confirmed that the antibody binds to a subset of the amino acids bound by ACE2,” they said.

This, the researchers explained, provides an explanation for why the B38 antibody confers such strong neutralizing effects.

They suggest that a “cocktail” containing both antibodies could provide direct therapeutic benefits for COVID-19 patients.

“The finding regarding the viral spike epitopes could also aid the development of small molecule antivirals and vaccine candidates to fight the SARS-CoV-2 virus,” the researchers added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Nursing student suicide: Three students arrested in Kerala

Nadda’s letter to Kharge full of falsehoods: Cong

10 month baby gets new heart, new life

Actress Kasthuri released from jail, says ‘I thank those who made me raging storm’

Kidnapped for ransom in 1998, 26/11 survivor Gautam Adani faces biggest trial

100 engineering colleges in Karnataka to be ‘adopted’ by corporates by next year: IT Minister Kharge

Siddaramaiah defends BPL ration card cancellation, says only ineligible beneficiaries affected

Related Articles More

India-US ties have strong foundation: White House confident in navigating crisis over Adani bribery charges

PM Modi leaves for home after concluding three-nation visit

China announces new policy measures to protect its exports from Trump’s new tariff threat

Pak government prepares for proposed protest by former PM Imran Khan’s party on Nov 24

Gangster Lawrence Bishnoi’s brother Anmol arrested in US, lodged in Iowa jail

MUST WATCH

Christmas Cake Fruit Mixing

DK Shivakumar

Rose Cultivation

Geethotsava

Naxal Operation


Latest Additions

Mangaluru: POCSO case – Convict sentenced to 20 years in prison

Nursing student suicide: Three students arrested in Kerala

Sampaje: Financial fraud using Google Pay reported

Nadda’s letter to Kharge full of falsehoods: Cong

Kundapur: Several injured after insulator truck rams into Innova car on NH-66

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.